catapres-tts
carsl consulting - clonidine 7.5mg - transdermal patch - 7.5 mg - active: clonidine 7.5mg excipient: calcium stearate - catapres-tts is indicated for the treatment of mild to moderate hypertension. it can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.
catapres 100
boehringer ingelheim pty ltd - clonidine hydrochloride -
catapres ampoules 150 micrograms in 1 ml solution for injection
boehringer ingelheim limited - clonidine hydrochloride - solution for injection - 0.15 micromole(s) - imidazoline receptor agonists; clonidine
catapres 150micrograms/1ml solution for injection ampoules
glenwood gmbh - clonidine hydrochloride - solution for injection - 150microgram/1ml
catapres tablets 150mcg (カタプレス錠150μg)
medical parkland k.k. - clonidine hydrochloride - white tablet diameter: 8.0mm, thickness: 2.6mm)
catapres clonidine hydrochloride tablet
remedyrepack inc. - clonidine hydrochloride (unii: w76i6xxf06) (clonidine - unii:mn3l5rmn02) - clonidine hydrochloride 0.1 mg
dixarit tab 0.025mg tablet
boehringer ingelheim (canada) ltd ltee - clonidine hydrochloride - tablet - 0.025mg - clonidine hydrochloride 0.025mg - central alpha-agonists
dixarit 0.025 milligram tablets
boehringer ingelheim limited - clonidine hydrochloride - tablets - 0.025 milligram - other antimigraine preparations
catapres 150
boehringer ingelheim pty ltd - clonidine hydrochloride -
catapres 150 tablets
boehringer ingelheim pty ltd - clonidine hydrochloride -